The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
p53 in ferroptosis regulation: the new weapon for the old guardian
Open accessAbstract
Although the conventional activities of p53 such as cell cycle arrest, senescence, and apoptosis are well accepted as the major checkpoints in stress responses, accumulating evidence implicates the importance of other tumor suppression mechanisms. Among these unconventional activities, an iron-dependent form of non-apoptotic cell death, termed ferroptosis, attracts great interest. Unlike apoptotic cell death, activation of p53 alone is not sufficient to induce ferroptosis directly; instead, through its metabolic targets, p53 is able to modulate the ferroptosis response in the presence of ferroptosis inducers such as GPX4 inhibitors or high levels of ROS. Here, we review the role of ferroptosis in p53-mediated tumor suppression, with a focus on what cellular factors are critical for p53-dependent ferroptosis during tumor suppression and how p53 modulates both the canonical (GPX4-dependent) and the non-canonical (GPX4-independent) ferroptosis pathways. We also discuss the possibility of targeting p53-mediated ferroptotic responses for the treatment of human cancers and potentially, other diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It is known that p53 modulates ferroptosis, an iron-dependent, nonapoptotic form of cell death induced by lipid peroxidation in response to high levels of ROS [ 71 ].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ma, S., Sun, L., Wu, W., Jiang-li, W., Sun, Z., & Ren, J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.551318 · Cited by 202
RetractedFerroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Ferroptosis: mechanisms, biology and role in disease
Jiang, X., Stockwell, B. R., & Conrad, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00324-8 · Cited by 7,973
Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease
Stockwell, B. R., Friedmann Angeli, J. P., Bayir, H., Bush, A. I., Conrad, M., Dixon, S. J., Fulda, S., Gascón, S., Hatzios, S. K., Kagan, V. E., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.021 · Cited by 7,695
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Doll, S., Proneth, B., Tyurina, Y. Y., Panzilius, E., Kobayashi, S., Ingold, I., Irmler, M., Beckers, J., Aichler, M., Walch, A., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2239 · Cited by 4,293
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
Bersuker, K., Hendricks, J. M., Li, Z., Magtanong, L., Ford, B., Tang, P. H., Roberts, M. A., Tong, B., Maimone, T. J., Zoncu, R., et al. (2019) · Nature · doi:10.1038/s41586-019-1705-2 · Cited by 3,703
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Self-citationFSP1 is a glutathione-independent ferroptosis suppressor
Doll, S., Freitas, F. P., Shah, R., Aldrovandi, M., da Silva, M. C., Ingold, I., Goya Grocin, A., Xavier da Silva, T. N., Panzilius, E., Scheel, C. H., et al. (2019) · Nature · doi:10.1038/s41586-019-1707-0 · Cited by 3,341
Research works printed but not linked: 1
- Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 2015;520:57–62. · DOI · Paper page
Cited by
Sorted by citations
Items 101–200 of 540
Ferroptosis: A mixed blessing for infectious diseases
Xiao, L.-Y., Huang, H., Fan, S., Zheng, B., Wu, J., Zhang, J., Pi, J., & Xu, J.-F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.992734 · Cited by 37
Recent findings on the role of wild-type and mutant p53 in cancer development and therapy
Babamohamadi, M., Babaei, E., Salih, B. A., Babamohammadi, M., Azeez, H. J., & Othman, G. Q. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.903075 · Cited by 39
The role of microRNAs in ferroptosis
Guo, L., Zhang, Q., & Liu, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1003045 · Cited by 32
Self-citationFerroptosis: A new therapeutic target for bladder cancer
Zeng, F. J., Lan, Y., Wang, N., Huang, X., Zhou, Q., & Wang, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1043283 · Cited by 35
Gene expression in organoids: an expanding horizon
Smirnov, A., Melino, G., & Candi, E. (2023) · Biology Direct · doi:10.1186/s13062-023-00360-2 · Cited by 33
Defense systems to avoid ferroptosis caused by lipid peroxidation-mediated membrane damage
Fujii, J., & Yamada, K. (2023) · Free Radical Research · doi:10.1080/10715762.2023.2244155 · Cited by 38
Živanović, N., Lesjak, M. M., Simin, N. Đ., & Srai, S. K. (2024) · Antioxidants · doi:10.3390/antiox13030334 · Cited by 33
Khan, G., Hussain, M. S., Khan, Y., Fatima, R., Ahmad, S., Sultana, A., & Alam, P. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149776 · Cited by 35
Liu, H., Yan, J., Guan, F., Jin, Z., Xie, J., Wang, C., Liu, M., & Liu, J. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2023.159287 · Cited by 33
Ferroptosis in pulmonary fibrosis: an emerging therapeutic target
Wang, C., Hua, S., & Song, L. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1205771 · Cited by 32
Chen, J., Chen, S., & Chen, G. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2023.78 · Cited by 33
Lipocalin-2: A Nurturer of Tumor Progression and a Novel Candidate for Targeted Cancer Therapy
Živalj, M., Ginderachter, J. A. V., & Stijlemans, B. (2023) · Cancers · doi:10.3390/cancers15215159 · Cited by 35
Upadhyay, P. R., Starner, R. J., Swope, V. B., Wakamatsu, K., Ito, S., & Abdel-Malek, Z. A. (2022) · Antioxidants · doi:10.3390/antiox11061204 · Cited by 30
Nanomedicine-induced programmed cell death enhances tumor immunotherapy
Lu, J., Tai, Z., Wu, J., Li, L., Zhang, T., Liu, J., Zhu, Q., & Chen, Z. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.09.018 · Cited by 32
Application of natural products in regulating ferroptosis in human diseases
Deng, L., Tian, W., & Luo, L. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155384 · Cited by 32
Ferroptosis: mechanism, immunotherapy and role in ovarian cancer
Guo, K., Lu, M., Bi, J., Yao, T., Gao, J., Ren, F., & Zhu, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1410018 · Cited by 33
Programmed cell death network in cancer drug resistance: A framework for therapeutic intervention
Guo, D., Guo, Y., Zhu, C., Liao, Y., Lin, Z., Zhang, H., Zhang, W., & Zou, Z. (2026) · Drug Resistance Updates · doi:10.1016/j.drup.2026.101387 · Cited by 36
Kayadiol exerted anticancer effects through p53-mediated ferroptosis in NKTCL cells
He, C., Wang, C., Liu, H., & Shan, B. (2022) · BMC Cancer · doi:10.1186/s12885-022-09825-5 · Cited by 31
Sun, Y., Tang, L., Kan, X., Tan, L., Song, C., Qiu, X., Liao, Y., Nair, V., Ding, C., Liu, X., et al. (2024) · Journal of Virology · doi:10.1128/jvi.01897-23 · Cited by 30
Liu, L., Wen, T., Xiao, Y., Chen, H., Yang, S., & Shen, X. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118726 · Cited by 34
p53 in colorectal cancer: from a master player to a privileged therapy target
Yan, S., Zhan, F., He, Y., Zhu, Y., & Ma, Z. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06566-4 · Cited by 33
p53: A Regulator of Ferroptosis Induced by Galectin-1 Derived Peptide 3 in MH7A Cells
Hu, J., Zhang, R., Chang, Q., Ji, M.-L., Zhang, H., Geng, R., Li, C., & Wang, Z. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.920273 · Cited by 30
Paeoniflorin suppresses ferroptosis after traumatic brain injury by antagonizing P53 acetylation
Zhi, S., Cui, Y., Liu, Y., Zhang, J., Li, X.-J., Sheng, B., Chen, X.-X., Yan, C., Li, W., Mao, J.-N., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155940 · Cited by 30
Self-citationZou, F., Zou, J., Du, Q., Liu, L., Ding, L., Zhao, L., Tang, M., Zuo, L., & Sun, Z. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118732 · Cited by 32
Zhu, J., Zhou, W., Yao, Y., Zhou, X., Ma, X., Zhang, B., Yang, Z., Tang, B., Zhu, H., & Li, N. (2024) · ACS Nano · doi:10.1021/acsnano.4c11278 · Cited by 29
Ferroptosis and immunotherapy: Breaking barriers in cancer treatment resistance
Ebrahimnezhad, M., Valizadeh, A., & Yousefi, B. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104907 · Cited by 30
Current progress of ferroptosis study in ovarian cancer
Tan, Z., Huang, H., Sun, W., Li, Y., & Jia, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.966007 · Cited by 29
The PTBP1‑NCOA4 axis promotes ferroptosis in liver cancer cells
Yang, H., Sun, W., Bi, T., Wang, Q., Wang, W., Xu, Y., Liu, Z., & Li, J. (2023) · Oncology Reports · doi:10.3892/or.2023.8482 · Cited by 33
Che, B., Du, Y., Yuan, R., Xiao, H., Zhang, W., Shao, J., Lu, H., Yu, Y., Xiang, M., Hao, L., et al. (2023) · Oncogene · doi:10.1038/s41388-023-02843-y · Cited by 29
p53 mutation and deletion contribute to tumor immune evasion
Liu, S. M., Liu, T., Jiang, J., Guo, H., & Yang, R. L. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1088455 · Cited by 31
Shi, J., Yang, M. M., Yang, S., Fan, F., Zhang, J., Miao, Y., Hua, Y., Zhang, J., Cheng, Y., Liu, S., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155489 · Cited by 30
Yao, Z., Jia, F., Wang, S., Jiao, Q., Du, X., Chen, X., & Jiang, H. F. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.06.020 · Cited by 29
Harnessing Antioxidants in Cancer Therapy: Opportunities, Challenges, and Future Directions
Liu, Y., Wu, G., Feng, L., Li, J., Xia, Y., Guo, W., & Zhao, K. (2025) · Antioxidants · doi:10.3390/antiox14060674 · Cited by 32
Self-citationFerroptosis in Chronic Liver Diseases: Opportunities and Challenges
Zhou, G., Fu, Y., Liu, W., Mu, Y., Zhang, H., Chen, J., & Liu, P. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.928321 · Cited by 29
Ferroptosis-associated genes and compounds in renal cell carcinoma
He, C., Li, Q., Wu, W., Liu, K., Li, X., Zheng, H., & Lai, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1473203 · Cited by 29
Ferroptosis and renal fibrosis: mechanistic insights and emerging therapeutic targets
Lyu, G., Liao, H., & Li, R. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2498629 · Cited by 28
Targeting and activation of macrophages in leishmaniasis. A focus on iron oxide nanoparticles
Palomino-Cano, C., Moreno, E., Irache, J. M., & Espuelas, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1437430 · Cited by 29
Cheng, H., Wang, X., Yao, J., Yang, C., & Liu, J. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s488655 · Cited by 29
Advancement in understanding the role of ferroptosis in rheumatoid arthritis
Li, L., Guo, H., Chen, X., Liu, Y., Wang, R., Zheng, X., Huang, X., Zhou, Q., & Wang, Y. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1036515 · Cited by 26
Self-citationMicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response
Kawano, I., & Adamcová, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1055911 · Cited by 26
Cao, Y., Xiao, W., Liu, S., & Zeng, Y. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1080344 · Cited by 27
Dawi, J., Affa, S., Gonzalez, E., Misakyan, Y., Nikoghosyan, D., Hajjar, K., Kades, S., Fardeheb, S., Mirzoyan, H., & Venketaraman, V. (2024) · Biomedicines · doi:10.3390/biomedicines12030558 · Cited by 27
Molecular Mechanisms of Ferroptosis and Its Role in Viral Pathogenesis
Huang, R.-W., Wu, J., Ma, Y., & Kang, K. (2023) · Viruses · doi:10.3390/v15122373 · Cited by 26
Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma
Li, L., Wang, X., Xu, H., Liu, X., & Xu, K. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.947208 · Cited by 25
Opportunities and challenges related to ferroptosis in glioma and neuroblastoma
Chi, H., Li, B., Wang, Q., Gao, Z., Feng, B., Xue, H., & Li, G. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1065994 · Cited by 24
Indeglia, A., & Murphy, M. E. (2024) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2024.2344465 · Cited by 27
The interplay of transition metals in ferroptosis and pyroptosis
Vana, F., Szabo, Z., Masařík, M., & Kratochvílová, M. (2024) · Cell Division · doi:10.1186/s13008-024-00127-9 · Cited by 26
Ulhaq, Z. S., Ogino, Y., & Tse, W. K. F. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.04.096 · Cited by 24
Molecular therapy of cardiac ischemia–reperfusion injury based on mitochondria and ferroptosis
Wang, R., Chen, X., Li, X., & Wang, K. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02346-z · Cited by 25
Zhang, Y., Huang, Z., Li, K., Xie, G., Feng, Y., Wang, Z., Li, N., Liu, R., Ding, Y., Wang, J., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02920-w · Cited by 25
Mechanisms and therapeutic targets of ferroptosis: Implications for nanomedicine design
Zhang, M., Guo, M., Gao, Y., Wu, C., Pan, X., & Huang, Z. (2024) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2024.03.001 · Cited by 26
Ferroptosis: a potential target for acute lung injury
Wen, Y., Liu, Y., Liu, W., Liu, W., Dong, J., Liu, Q., Yu, Z., Ren, H., & Hao, H. (2024) · Inflammation Research · doi:10.1007/s00011-024-01919-z · Cited by 26
Self-citationZhang, J., Ding, W. B., Yin, Z., Liu, S., Zhao, M., Xu, Y. Q., Liu, J., Pan, W. D., Peng, S., Cheng, W., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae208 · Cited by 23
Ma, S., Xie, F., Wen, X., Adzavon, Y. M., Zhao, R., Zhao, J., Li, H., Li, Y., Liu, J., Liu, C., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107490 · Cited by 23
The mist of ferroptosis: The Orpheus journey of mitochondria - Exploring the symphony of cell fate
Jiang, Y., Liu, X., & Sun, M. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145472 · Cited by 27
The Role of Ferroptosis in Acute Kidney Injury
Zhang, J., Wang, B., Yuan, S., He, Q., & Jin, J. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.951275 · Cited by 23
Ferroptosis: Opportunities and Challenges in Treating Endometrial Cancer
Wu, J., Zhang, L., Wu, S., & Liu, Z. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.929832 · Cited by 23
Ferroptosis Signaling Pathways: Alzheimer's Disease
Maheshwari, S. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2084-3561 · Cited by 23
The mechanisms crosstalk and therapeutic opportunities between ferroptosis and ovary diseases
Yao, Y., Wang, B., Jiang, Y., Guo, H. W., & Li, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1194089 · Cited by 25
Ashoub, M. H., Amiri, M., Razavi, R., Dawi, E. A., Farsinejad, A., Divsalar, F., & Salavati‐Niasari, M. (2023) · Results in Engineering · doi:10.1016/j.rineng.2023.101479 · Cited by 23
Targeting ferroptosis in cancer: from mechanistic insights to therapeutic approaches
Wang, J., Guo, D., Jiang, S., Wu, W., & Gao, X. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00416-5 · Cited by 27
Ferroptosis Biology and Implication in Cancers
Qu, C., Peng, Y., & Liu, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.892957 · Cited by 22
Molecular mechanism of ferroptosis and its role in the occurrence and treatment of diabetes
Du, G.-H., Zhang, Q., Huang, X., & Wang, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1018829 · Cited by 22
Marine Alkaloid Lepadins E and H Induce Ferroptosis for Cancer Chemotherapy
Wang, W., Ma, F., Cheung, Y. T., Zeng, G., Zhou, Y., Chen, Z., Liang, L., Luo, T., & Tong, R. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00659 · Cited by 23
Competing endogenous RNA networks and ferroptosis in cancer: novel therapeutic targets
Orang, F. N., & Shadbad, M. A. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06732-4 · Cited by 25
Zhang, J., Tian, T., Li, X., Xu, K. L., Lu, Y., Li, X., Zhao, X., Cui, Z., Wang, Z., Zhou, Y., et al. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70271 · Cited by 27
Xu, G., Zhang, J., Shao, C., Wu, H., Shen, J., Wang, Y., Li, Y., Li, C., Yu, L., Zhou, H., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.06.013 · Cited by 24
Mutation of TP53 Confers Ferroptosis Resistance in Lung Cancer Through the FOXM1/MEF2C Axis
Peng, M., Hu, Q., Wu, Z., Wang, B., Wang, C., & Yu, F. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.05.003 · Cited by 22
Ferroptosis, a subtle talk between immune system and cancer cells: To be or not to be?
Zhou, Q., Tao, C., Yuan, J., Pan, F., & Wang, R. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115251 · Cited by 21
Chen, H., Xie, W., Peng, Z., Liu, Y., Li, H., & Huang, W. (2023) · Shock · doi:10.1097/shk.0000000000002224 · Cited by 21
Self-citationAZD1775 synergizes with SLC7A11 inhibition to promote ferroptosis
Chen, X., Ling, H., Huang, Y., Dong, H., Xie, B., Hao, Q., & Zhou, X. Y. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2589-1 · Cited by 27
Wen, Z., Xia, G., Liang, C., Wang, X., Huang, J., Zhang, L., Shan, D., Song, W. C., & Cao, X. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0141 · Cited by 22
Yadav, V. K., Choudhary, N., Gacem, A., Verma, R. K., Hasan, M. A., Imam, M. T., Almalki, Z. S., Yadav, K. K., Park, H.-K., Ghosh, T., et al. (2023) · Redox Report · doi:10.1080/13510002.2023.2269331 · Cited by 22
Pandey, R., Chiu, C., & Wang, L. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c01040 · Cited by 20
Zhou, D., Liang, Q., Ge, X., & Xu, J. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.02.020 · Cited by 20
Lu, L., Jifu, C., Xia, J., & Wang, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116753 · Cited by 26
High Uric Acid Orchestrates Ferroptosis to Promote Cardiomyopathy Via ROS-GPX4 Signaling
Xu, C., Wu, M., Yu, W., Xie, D., Wang, Q., Chen, B., Xi, Y., Yu, L., Yan, Y., Yamamoto, T., et al. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0473 · Cited by 20
Emerging role and therapeutic implications of p53 in intervertebral disc degeneration
Wang, Y., Hu, S., Zhang, W., Zhang, B.-F., & Yang, Z. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01730-5 · Cited by 20
Xu, J., He, X., Li, L., Zhang, L., Li, M., Mu, Y., Yang, X., Li, S., Feng, Y., Zuo, Z., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00912-5 · Cited by 22
Bypassing the guardian: regulated cell death pathways in p53-mutant cancers
Chung, J., & Knutson, B. A. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00751-5 · Cited by 22
Ferroptosis in lymphoma: Emerging mechanisms and a novel therapeutic approach
Zhou, Q., Li, T., Qin, Q., Huang, X., & Wang, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1039951 · Cited by 21
Ye, S., Liu, Y., Zhang, T., Feng, H., Liu, Y., & Ma, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1068432 · Cited by 19
Self-citationFang, Y., Tan, Q., Zhou, H., Xu, J., & Gu, Q. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114905 · Cited by 19
Wild-type and mutant p53 in cancer-related ferroptosis. A matter of stress management?
Corazzari, M., & Collavin, L. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1148192 · Cited by 21
Tkachenko, A. S., Onishchenko, A. I., Myasoedov, V. V., Yefimova, S. L., & Havránek, O. (2023) · Nanotoxicology · doi:10.1080/17435390.2023.2203239 · Cited by 21
Consoli, V., Fallica, A. N., Sorrenti, V., Pittalà, V., & Vanella, L. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0179 · Cited by 21
Zhong, D., Quan, L., Hao, C., Chen, J., Qiao, R., Lin, T.-F., Ying, C., Sun, D., Jia, Z., & Sun, Y. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06236-7 · Cited by 21
NAD+: An old but promising therapeutic agent for skeletal muscle ageing
Xu, Y., & Xiao, W. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102106 · Cited by 20
Lin, G., Jiang, H., Zhang, Z., Ning, L. G., Zhang, W., Peng, L., Xu, S., Sun, W., Tao, S., Zhang, T., et al. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166968 · Cited by 19
Iron Metabolism and Ferroptosis in Early Brain Injury after Subarachnoid Haemorrhage
Ge, S., Jing, Z., Wang, L., Cui, X., Zhang, X., & Wang, X. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04218-0 · Cited by 20
Liu, M., Liu, Y., Cai, Y., Gu, Y., Zhu, Y.-Q., Zhang, N., Zhu, W., Liu, Y., Yu, L., Zhang, Q., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402110 · Cited by 18
Self-citationLipoxygenases at the Intersection of Infection and Carcinogenesis
Amoah, A.-S., Pestov, N. B., Korneenko, T. V., Prokhorenko, I. A., Куракин, Г. Ф., & Barlev, N. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073961 · Cited by 23
Exploring the future of research in the Tp53 field
Levine, A. J. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00986-1 · Cited by 18
Yuan, F., Han, S., Li, Y., Li, S., Li, D., Tian, Q., Feng, R., Shao, Y., Li, X., Wang, J., et al. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110299 · Cited by 17
Sun, Q., Tu, K.-R., Xu, Q., Li, Y., Yang, S., Wang, J., Lv, L., Liu, H., & Cai, L. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.10.025 · Cited by 20
Ferroptosis and its emerging role in esophageal cancer
Maimaitizunong, R., Wang, K., & Li, H. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1027912 · Cited by 18
Xu, Y., Pan, F., Liu, L., Xu, X., Zhang, L., Wang, J., Tao, Y., Li, X., Li, X., & Wang, Y. (2023) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200410 · Cited by 17
Hu, G., Cheng, W., Gu, M., Hang, L., Yang, W., Liu, T., Li, W., Shi, X., Liu, M., & Tian, J. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.152408 · Cited by 17
Wei, X., Fan, X., Chai, W., Xiao, J., Zhao, J., He, A., Tang, X., Li, F., & Guo, S. (2025) · Food & Function · doi:10.1039/d5fo00475f · Cited by 16
Ju, W., Zhao, S., Li, D., Zhang, J., Xiang, S., & Lian, F. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1546041 · Cited by 16
Metadata
- Authors
- Liu, Y., & Gu, W.
- Affiliations
- Herbert Irving Comprehensive Cancer Center (US)
- Corresponding author
- Gu, Wei
- ORCID
- Venue
- Cell Death & Differentiation
- Published
- 2022-01-27
- Volume
- 29
- Issue
- 5
- Pages
- 895-910
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- PMC
- PMC9091200
- OpenAlex
- W4210576858
- Cited by
- 540
- References
- 141
- Citations by year
- 2026: 88 · 2025: 153 · 2024: 128 · 2023: 110 · 2022: 60
- FWCI
- 19.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cell Death and Differentiation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35CA253059, R01CA254970)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- p53, ferroptosis, tumor suppression, GPX4, iron metabolism, reactive oxygen species, non-apoptotic cell death, cancer therapy
- MeSH terms
- Ferroptosis, Humans, Neoplasms, Tumor Suppressor Protein p53, Apoptosis, Reactive Oxygen Species
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review